Next GEN Act of 2026
The Next GEN Act of 2026 modifies the Drug Price Negotiation Program to include a specific category of medications called engineered cyclic peptides. This change extends the time before these drugs can be negotiated for lower prices from seven years to eleven years. The bill defines these peptides as synthetic, amino acid-based drugs that are self-administered and created using genetic library screening methods. By adjusting the timeline, the legislation directly affects pharmaceutical companies and the government agencies responsible for setting drug prices under the program.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
President
Introduced May 15, 2026
Last action May 15, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
May 15, 2026
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 15, 2026
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8857
Scope: US
Hi! I can help you understand HR 8857. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline